Learn about the emerging companies, finance trends, and strategic drivers impacting the global medtech industry.
AtriAN Medical is developing an innovative solution for the treatment of AF that utilizes micro-Pulsed Electric Field (mPEF)
Spark Biomedical's FDA-cleared Transcutaneous Auricular Neurostimulation (tAN™) is a non-invasive wearable treatment technology for opioid withdrawal relief.
CoLabs is developing The Ventor, an emergency airway and ventilation system to manage the patients airway during cardiac arrest.
AiM Medical Robotics is developing a portable MRI compatible surgical robot for use in the OP and MRI suite. The system is being designed for the treatment of functional brain disorders (e.g. epilepsy, Parkinson's disease).
Wearable Artificial Organs is developing truly portable solutions for use in patients with End Stage Renal Disease (ESRD).
Wearable technology designed to treat the root cause of female incontinence. The Innovo device engages the pelvic floor muscles via 30 minute sessions that have been clinically proven to reduce and eliminate leaks due to stress urinary incontinence.
Pulse Infoframe has developed a robust platform for accelerating evidence generation and collaborative research through quality real-world data (“RWD”) at scale.
ATRO Medical is developing Trammpolin, a prosthetic meniscus made of anatomically shaped polymer for the replacement of damaged menisci.
Entvantage Dx is an in-vitro diagnostic company dedicated to reducing antibiotics for ENT illnesses.
At LSI USA '22 Emerging Medtech Summit, Life Science Intelligence presented Industry Legend, Manny Villafaña, with the LSI Lifetime Achievement Award in Medical Devices.
How will Web3, NFTs, and Decentralized Science Impact the future of healthcare?
True Vision Treatment (TVT) is Yolia Health's two step therapeutic process for the treatment of vision problems like presbyopia and myopia.
Developing a miniaturized neuromodulation device for therapeutic applications.
Surgical Automations is developing autonomous surgical robots for endoscopic diagnostic and interventional procedures.
Molecular breast imaging (MBI) technology to more accurately diagnose early-stage breast cancer in women with dense breast tissue.
Unintended retained foreign object (URFO) is the #1 "never-event" in hospitals. Melzi Sharps Finder helps surgeons inspect the surgical area for metal objects during open, laparoscopic, and robotic surgeries.
The Pulsify Patch is intended to offer new insights into patients' cardiovascular health that can't be captured using traditional catheter and ultrasound transducer-based approaches.
This panel will explore how a new model of incubators and early-stage corporate investors are driving innovation.
Let's find out directly from major strategics on what deals they are hunting for and hear their outlook on M&A activity in the coming year.
Let's dig deep and find out what these VCs are looking for and find out where they are focusing their next round of investments.
This panel will explore different methods to raise capital and explore why these successful CEOs chose their path. We'll discuss the challenges CEOs in our space experience, and address how those challenges can be overcome.
In 2022, how will major providers decide which products meet their needs? How do they decide who wins, and why do so many products never even get an evaluation? What other market trends, nuances, and inside guidance should innovators (and their investors) be thinking about?
A lively discussion with CEOs that have successfully raised multiple rounds of capital, and now are accelerating into the next stages of growth.
This panel will explore one of the hottest areas in medtech. Where are we and how far do we have to go? Hear the views of the investor, innovator, and strategic.
How have recent market dynamics changed the strategies of active medtech VCs? What kind of deals are they looking and what is catching their interest at LSI USA '22?
Let's get into it with senior executives from top strategics and find out what kind of deals they are looking for, right now.
Hear a real-time clinical perspective on the most important takeaways of LSI USA '22 that we should all be paying attention to.
This panel gives the different perspectives on how to accelerate time to market from the view of operators, survive providers, and investors.
